These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20353307)

  • 1. Viability and engraftment of hematopoietic progenitor cells after long-term cryopreservation: effect of diagnosis and percentage dimethyl sulfoxide concentration.
    Veeraputhiran M; Theus JW; Pesek G; Barlogie B; Cottler-Fox M
    Cytotherapy; 2010 Oct; 12(6):764-6. PubMed ID: 20353307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
    Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
    Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
    Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
    Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Storage Duration of Autologous Stem Cell Preparations Has No Impact on Hematopoietic Recovery after Transplantation.
    Lisenko K; Pavel P; Kriegsmann M; Bruckner T; Hillengass J; Goldschmidt H; Witzens-Harig M; Ho AD; Wuchter P
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):684-690. PubMed ID: 28013016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced dimethyl sulfoxide concentrations successfully cryopreserve human hematopoietic stem cells with multi-lineage long-term engraftment ability in mice.
    Gilfanova R; Auclair KM; Hui A; Norris PJ; Muench MO
    Cytotherapy; 2021 Dec; 23(12):1053-1059. PubMed ID: 34454842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term storage of peripheral blood stem cells frozen and stored with a conventional liquid nitrogen technique compared with cells frozen and stored in a mechanical freezer.
    McCullough J; Haley R; Clay M; Hubel A; Lindgren B; Moroff G
    Transfusion; 2010 Apr; 50(4):808-19. PubMed ID: 19912586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
    Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
    Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-thaw viability of cryopreserved hematopoietic progenitor cell grafts: does it matter?
    Vrhovac R; Perić Z; Jurenec S; Kardum-Skelin I; Jelić-Puskarić B; Jaksić B
    Coll Antropol; 2010 Mar; 34(1):163-9. PubMed ID: 20432746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryopreservation of hematopoietic cells using a pre-constituted, protein-free cryopreservative solution with 5% dimethyl sulfoxide.
    Trummer T; Fox R; Koç JR; de Lima M; Otegbeye F
    Cytotherapy; 2020 Nov; 22(11):613-616. PubMed ID: 32600975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
    Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
    Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term cryopreservation in 5% DMSO maintains unchanged CD34(+) cells viability and allows satisfactory hematological engraftment after peripheral blood stem cell transplantation.
    Abbruzzese L; Agostini F; Durante C; Toffola RT; Rupolo M; Rossi FM; Lleshi A; Zanolin S; Michieli M; Mazzucato M
    Vox Sang; 2013 Jul; 105(1):77-80. PubMed ID: 23384290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of laboratory procedures on postthawing cell viability and hematopoietic engraftment after autologous peripheral blood stem cell transplantation.
    Belisário AR; da Costa Funes AP; Luz JR; de Almeida Costa L; Furtado MDSBS; Martins MC; Cruz NG; Pederzoli PRMP; de Andrade RK; Libânio MRIS; de Lima Prata K
    Transfusion; 2021 Apr; 61(4):1202-1214. PubMed ID: 33569783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term storage at -80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant.
    Galmés A; Besalduch J; Bargay J; Novo A; Morey M; Guerra JM; Duran MA
    Transfusion; 1999 Jan; 39(1):70-3. PubMed ID: 9920169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of the freezing process for hematopoietic progenitor cells: effect of precooling, initial dimethyl sulfoxide concentration, freezing program, and storage in vapor-phase or liquid nitrogen on in vitro white blood cell quality.
    Dijkstra-Tiekstra MJ; Setroikromo AC; Kraan M; Gkoumassi E; de Wildt-Eggen J
    Transfusion; 2014 Dec; 54(12):3155-63. PubMed ID: 25109216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the effect of cryoprotectant medium composition to viability of autologous hematopoietic cells collected by leukapheresis.
    Kozlowska-Skrzypczak M; Kubiak A; Bembnista E; Matuszak P; Komarnicki M
    Transplant Proc; 2014 Oct; 46(8):2535-8. PubMed ID: 25380858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells.
    Smagur A; Mitrus I; Giebel S; Sadus-Wojciechowska M; Najda J; Kruzel T; Czerw T; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Holowiecki J
    Vox Sang; 2013 Apr; 104(3):240-7. PubMed ID: 23046417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-clinical assessment of the Lovo device for dimethyl sulfoxide removal and cell concentration in thawed hematopoietic progenitor cell grafts.
    Mfarrej B; Bouchet G; Couquiaud J; Regimbaud L; Binninger S; Mercier M; Lemarié C; Houzé P; Chabannon C; Calmels B
    Cytotherapy; 2017 Dec; 19(12):1501-1508. PubMed ID: 29037941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of the post-thaw CD34+ count with and without DMSO removal in the setting of autologous stem cell transplantation.
    Rohner N; Passweg JR; Tsakiris DA; Halter JP; Heim D; Buser AS; Infanti L; Holbro A
    Transfusion; 2019 Mar; 59(3):1052-1060. PubMed ID: 30556582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft.
    Liseth K; Abrahamsen JF; Bjørsvik S; Grøttebø K; Bruserud Ø
    Cytotherapy; 2005; 7(4):328-33. PubMed ID: 16162454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryopreservation of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide at -80 degrees C without rate-controlled freezing.
    Galmés A; Besalduch J; Bargay J; Matamoros N; Durán MA; Morey M; Alvarez F; Mascaró M
    Transfusion; 1996 Sep; 36(9):794-7. PubMed ID: 8823452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.